Julia Robinson is our clinical and science editor.
Recommending the use of e-cigarettes, smokeless tobacco or new heated tobacco products to smokers instead of conventional cigarettes, is just “replacing a very harmful product with a less, but still harmful, product”, the European Respiratory Society has said.
More than half of acute trusts in England failed to reduce their antibiotic use between 2017/2018 and 2018/2019, according to figures analysed by The Pharmaceutical Journal.
Despite the rise of resistant infections, national figures show that antibiotic use continues to grow in hospitals. However, some trusts in England are stepping up their stewardship efforts and achieving significant reductions. Here, three trusts share the secrets to their success.
Recent blog posts
In 2018, our most popular research briefings covered new areas of research that have been particularly topical this year — including medical cannabis, new antibiotics and e-cigarettes — as well as areas that have long been of interest to pharmacists, such as pain management and adherence.
Julia Robinson summarises the pertinent themes discussed during The Pharmaceutical Journal’s Twitter chat held on Wednesday 12 December 2018.
Catch up on this year’s most read clinical trial stories, many of which cover important research into adverse effects of commonly used drugs.